Navigating the Global Market for Polyclonal Antibodies: Opportunities and Barriers
The global biotechnology and life sciences sector is expanding at an unprecedented pace, and antibodies, particularly polyclonal antibodies (pAbs) continue to serve as essential tools across research, diagnostics, and therapeutic development. Known for their broad epitope recognition, strong signal amplification, and cross-species versatility, polyclonal antibodies remain indispensable in applications such as immunohistochemistry, ELISA, and Western […]
Continue Reading